Stephen Willey
Stock Analyst at Stifel Nicolaus
(4.19)
# 1,531
Out of 5,085 analysts
626
Total ratings
41.9%
Success rate
6.5%
Average return
Main Sectors:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CMPX Compass Therapeutics | Maintained: Buy | $6 | $0.7472 | +703.00% | 16 | Oct 27, 2026 | |
| ZYME Zymeworks | Maintained: Buy | $46 | $28.37 | +62.14% | 35 | Oct 26, 2026 | |
| BCAX Bicara Therapeutics | Reiterated: Buy | $45 | $16.89 | +166.43% | 16 | Oct 26, 2026 | |
| CELC Celcuity | Reiterated: Buy | $150 | $65.80 | +127.96% | 12 | Oct 26, 2026 | |
| INCY Incyte | Reiterated: Buy | $157 | $113.31 | +38.56% | 42 | Oct 26, 2026 | |
| CBIO Crescent Biopharma | Reiterated: Buy | $28 | $12.76 | +119.44% | 20 | Oct 16, 2026 | |
| NRIX Nurix Therapeutics | Reiterated: Buy | $40 → $41 | $25.55 | +60.47% | 31 | Oct 13, 2026 | |
| OABI OmniAb | Reiterated: Buy | $9 | $4.61 | +95.23% | 12 | Oct 7, 2026 | |
| CGEN Compugen | Reiterated: Buy | $4 | $1.88 | +113.33% | 11 | Oct 6, 2026 | |
| NKTX Nkarta | Reiterated: Buy | $10 | $1.83 | +446.45% | 27 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $18.33 | +118.22% | 25 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $65.11 | - | 56 | Sep 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $9.31 | +286.68% | 3 | Sep 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $7 | $1.69 | +314.20% | 7 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $7.79 | +182.41% | 2 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $2.19 | +82.65% | 36 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $13.22 | +202.57% | 10 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $16.69 | +109.71% | 6 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $12.08 | -25.50% | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $111 | $77.66 | +42.93% | 11 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $93.33 | +114.29% | 30 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $4.31 | +294.43% | 6 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $7.5 | $3.25 | +130.77% | 17 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $6.07 | n/a | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $20 | $6.59 | n/a | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.15 | n/a | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $18.45 | n/a | 15 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $6 | $1.12 | n/a | 17 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $5 | $0.5892 | n/a | 4 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $3.92 | n/a | 6 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $1 | $0.8698 | n/a | 15 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $27 | $1.07 | n/a | 4 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $1.45 | n/a | 11 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $21 | $35.77 | n/a | 5 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $160 | $2.35 | n/a | 1 | Mar 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $95 → $125 | $227.66 | n/a | 6 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $109 → $114 | $55.75 | n/a | 14 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $48 | $43.42 | n/a | 13 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $16 | $21.05 | n/a | 13 | Apr 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $2.5 | $0.000001 | n/a | 3 | Sep 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $26 | $14.27 | n/a | 2 | Apr 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $0.8421 | n/a | 1 | Feb 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $6.28 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $205.70 | n/a | 1 | May 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $6.54 | n/a | 5 | Dec 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $101 | - | n/a | 5 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $26 | $4.20 | n/a | 3 | Nov 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $7 | $49.91 | n/a | 2 | Apr 8, 2013 |
Compass Therapeutics
Oct 27, 2026
Maintained: Buy
Price Target: $6
Current: $0.7472
Upside: +703.00%
Zymeworks
Oct 26, 2026
Maintained: Buy
Price Target: $46
Current: $28.37
Upside: +62.14%
Bicara Therapeutics
Oct 26, 2026
Reiterated: Buy
Price Target: $45
Current: $16.89
Upside: +166.43%
Celcuity
Oct 26, 2026
Reiterated: Buy
Price Target: $150
Current: $65.80
Upside: +127.96%
Incyte
Oct 26, 2026
Reiterated: Buy
Price Target: $157
Current: $113.31
Upside: +38.56%
Crescent Biopharma
Oct 16, 2026
Reiterated: Buy
Price Target: $28
Current: $12.76
Upside: +119.44%
Nurix Therapeutics
Oct 13, 2026
Reiterated: Buy
Price Target: $40 → $41
Current: $25.55
Upside: +60.47%
OmniAb
Oct 7, 2026
Reiterated: Buy
Price Target: $9
Current: $4.61
Upside: +95.23%
Compugen
Oct 6, 2026
Reiterated: Buy
Price Target: $4
Current: $1.88
Upside: +113.33%
Nkarta
Sep 28, 2026
Reiterated: Buy
Price Target: $10
Current: $1.83
Upside: +446.45%
Sep 28, 2026
Reiterated: Buy
Price Target: $40
Current: $18.33
Upside: +118.22%
Sep 11, 2026
Reiterated: Hold
Price Target: n/a
Current: $65.11
Upside: -
Sep 11, 2026
Reiterated: Buy
Price Target: $36
Current: $9.31
Upside: +286.68%
Aug 17, 2026
Reiterated: Buy
Price Target: $8 → $7
Current: $1.69
Upside: +314.20%
Aug 14, 2026
Reiterated: Buy
Price Target: $22
Current: $7.79
Upside: +182.41%
Aug 14, 2026
Reiterated: Hold
Price Target: $4
Current: $2.19
Upside: +82.65%
Aug 14, 2026
Reiterated: Buy
Price Target: $40
Current: $13.22
Upside: +202.57%
Aug 11, 2026
Reiterated: Buy
Price Target: $35
Current: $16.69
Upside: +109.71%
Aug 6, 2026
Reiterated: Buy
Price Target: $8 → $9
Current: $12.08
Upside: -25.50%
Jul 31, 2026
Reiterated: Buy
Price Target: $111
Current: $77.66
Upside: +42.93%
Jul 17, 2026
Reiterated: Buy
Price Target: $200
Current: $93.33
Upside: +114.29%
Mar 18, 2026
Reiterated: Buy
Price Target: $17
Current: $4.31
Upside: +294.43%
Nov 5, 2025
Reiterated: Buy
Price Target: $9 → $7.5
Current: $3.25
Upside: +130.77%
Jun 24, 2025
Initiated Coverage: Buy
Price Target: $28
Current: $6.07
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: $25 → $20
Current: $6.59
Upside: n/a
Mar 12, 2025
Reiterated: Buy
Price Target: $4
Current: $1.15
Upside: n/a
Nov 15, 2024
Reiterated: Buy
Price Target: $4
Current: $18.45
Upside: n/a
May 14, 2024
Reiterated: Hold
Price Target: $7 → $6
Current: $1.12
Upside: n/a
May 13, 2022
Reiterated: Hold
Price Target: $9 → $5
Current: $0.5892
Upside: n/a
May 13, 2022
Reiterated: Hold
Price Target: $6 → $5
Current: $3.92
Upside: n/a
May 11, 2022
Reiterated: Hold
Price Target: $3 → $1
Current: $0.8698
Upside: n/a
Mar 12, 2021
Reiterated: Buy
Price Target: $25 → $27
Current: $1.07
Upside: n/a
Mar 11, 2021
Reiterated: Hold
Price Target: $6
Current: $1.45
Upside: n/a
Mar 29, 2019
Reiterated: Buy
Price Target: $18 → $21
Current: $35.77
Upside: n/a
Mar 14, 2019
Reiterated: Hold
Price Target: $160
Current: $2.35
Upside: n/a
Aug 6, 2018
Upgraded: Buy
Price Target: $95 → $125
Current: $227.66
Upside: n/a
Aug 6, 2018
Reiterated: Buy
Price Target: $109 → $114
Current: $55.75
Upside: n/a
Aug 6, 2018
Reiterated: Hold
Price Target: $55 → $48
Current: $43.42
Upside: n/a
Apr 27, 2018
Reiterated: Hold
Price Target: $17 → $16
Current: $21.05
Upside: n/a
Sep 26, 2017
Downgraded: Hold
Price Target: $13 → $2.5
Current: $0.000001
Upside: n/a
Apr 4, 2017
Reiterated: Buy
Price Target: $20 → $26
Current: $14.27
Upside: n/a
Feb 2, 2017
Reiterated: Buy
Price Target: $24
Current: $0.8421
Upside: n/a
Dec 2, 2016
Reiterated: Buy
Price Target: $23
Current: $6.28
Upside: n/a
May 31, 2016
Reiterated: Buy
Price Target: $200
Current: $205.70
Upside: n/a
Dec 2, 2015
Downgraded: Hold
Price Target: n/a
Current: $6.54
Upside: n/a
Mar 31, 2015
Downgraded: Hold
Price Target: $101
Current: -
Upside: n/a
Nov 7, 2014
Reiterated: Buy
Price Target: $31 → $26
Current: $4.20
Upside: n/a
Apr 8, 2013
Reiterated: Buy
Price Target: $11 → $7
Current: $49.91
Upside: n/a